galgravin has been researched along with Leishmaniasis in 2 studies
*Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arruda, CC; Baroni, AC; Bosquiroli, LS; Carvalho, DB; Cassamale, TB; Costa, EC; Kadri, MC; Matos, MF; Ojeda, M; Ximenes, TV | 1 |
| Bernardes, LSC; da Rosa, R; de Moraes, MH; Schenkel, EP; Steindel, M; Zimmermann, LA | 1 |
2 other study(ies) available for galgravin and Leishmaniasis
| Article | Year |
|---|---|
Antileishmanial Activity and Structure-Activity Relationship of Triazolic Compounds Derived from the Neolignans Grandisin, Veraguensin, and Machilin G.
Topics: Animals; Antiprotozoal Agents; Furans; Humans; Leishmania; Leishmaniasis; Lignans; Macrophages; Nitric Oxide; Structure-Activity Relationship | 2016 |
Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
Topics: Animals; Antiprotozoal Agents; Drug Design; Furans; Isoxazoles; Leishmania infantum; Leishmania mexicana; Leishmaniasis; Lignans; Molecular Structure; NADH, NADPH Oxidoreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanosoma cruzi | 2017 |